BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18283236)

  • 1. [The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies].
    Grzybowska-Izydorczyk O; Smolewski P
    Postepy Hig Med Dosw (Online); 2008 Feb; 62():55-63. PubMed ID: 18283236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
    Smolewski P; Robak T
    Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia.
    Grzybowska-Izydorczyk O; Cebula B; Robak T; Smolewski P
    Eur J Cancer; 2010 Mar; 46(4):800-10. PubMed ID: 20045309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
    Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
    Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
    Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
    Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitor of apoptosis protein family and its antagonists in acute leukemias.
    Wrzesień-Kuś A; Smolewski P; Sobczak-Pluta A; Wierzbowska A; Robak T
    Apoptosis; 2004 Nov; 9(6):705-15. PubMed ID: 15505413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia.
    Yamamoto K; Abe S; Nakagawa Y; Suzuki K; Hasegawa M; Inoue M; Kurata M; Hirokawa K; Kitagawa M
    Leuk Res; 2004 Nov; 28(11):1203-11. PubMed ID: 15380346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic.
    Balakrishnan K; Fu M; Onida F; Wierda WG; Keating MJ; Gandhi V
    Oncotarget; 2016 Jun; 7(26):39458-39472. PubMed ID: 27223062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
    Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
    Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional evaluation of the role of inhibitor of apoptosis proteins in chronic lymphocytic leukemia.
    Schliep S; Decker T; Schneller F; Wagner H; Häcker G
    Exp Hematol; 2004 Jun; 32(6):556-62. PubMed ID: 15183896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
    de Graaf AO; de Witte T; Jansen JH
    Leukemia; 2004 Nov; 18(11):1751-9. PubMed ID: 15457181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
    Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
    Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.
    Tamm I; Kornblau SM; Segall H; Krajewski S; Welsh K; Kitada S; Scudiero DA; Tudor G; Qui YH; Monks A; Andreeff M; Reed JC
    Clin Cancer Res; 2000 May; 6(5):1796-803. PubMed ID: 10815900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
    LaCasse EC; Baird S; Korneluk RG; MacKenzie AE
    Oncogene; 1998 Dec; 17(25):3247-59. PubMed ID: 9916987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
    Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
    Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
    Yang L; Cao Z; Yan H; Wood WC
    Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
    Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
    Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
    Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.